Logo-npj
Submitted: 07 Sep 2023
Accepted: 12 Nov 2023
ePublished: 28 Nov 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2024;13(1): e11658.
doi: 10.34172/npj.2023.11658
  Abstract View: 509
  PDF Download: 246

Mini-Review

Administration of N-acetylcysteine for contrast-induced acute kidney injury; an updated mini-review

Sam Mirfendereski 1 ORCID logo, Mahboobe Taghipour 2 ORCID logo, Farshad Yadollahi 3 ORCID logo, Hadi Taghavinejad 4* ORCID logo, Mahdieh Ahmadnia 4 ORCID logo

1 Department of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Internal Medicine, School of Medicine Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran
3 Departments of Medicine, Medical School, Shahrekord University of Medical Sciences, Shahrekord, Iran
4 Shahrekord University of Medical Sciences, Shahrekord, Iran
*Corresponding Author: Hadi Taghavinejad, Email: dr.taghavinejad@gmail.com

Abstract

Contrast-induced acute kidney injury (CI-AKI) is a potential complication of medical imaging procedures that use contrast media. It is important to identify and manage risk factors for contrast-induced nephropathy and to monitor patients for signs of renal damage after contrast administration. N-acetylcysteine (NAC) can prevent CI-AKI through multiple mechanisms of action, including reducing oxidative stress, improving renal hemodynamics, reducing inflammation, reducing apoptosis and fibrosis, reducing oxidative stress-induced DNA damage, reducing tubular cell injury, and reducing renal tubular cell apoptosis. However, the exact mechanisms of action may vary based on the specific study or context. Further research is needed to fully elucidate the molecular mechanisms of NAC in preventing CI-AKI.

Implication for health policy/practice/research/medical education:

N-acetylcysteine can improve renal hemodynamics by increasing nitric oxide production, reducing vasoconstriction, increasing prostaglandin synthesis, reducing oxidant stress-mediated renal tubular injury, and reducing inflammation. These effects can help prevent CI-AKI by improving renal blood flow and oxygenation. However, the exact mechanisms of action may vary based on the specific study or context. Further research is needed to fully elucidate the molecular mechanisms of NAC in improving renal hemodynamics.

Please cite this paper as: Mirfendereski S, Taghipour M, Yadollahi F, Taghavinejad H, Ahmadnia M. Administration of N-acetylcysteine for contrast-induced acute kidney injury; an updated mini-review. J Nephropharmacol. 2024;13(1):e11658. DOI: 10.34172/npj.2023.11658.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 510

Your browser does not support the canvas element.


PDF Download: 246

Your browser does not support the canvas element.